POS1216 POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME
S. Amikishiyev, A. Gül(Istanbul University), M. Kose(Istanbul University), R. Deniz(Istanbul University), Görkem Durak(Istanbul University), Murat Bektaş(Istanbul University), M. Erelel(Istanbul University), N. Koca(Istanbul University), B. Ince(Istanbul University), Yağmur Cantürk(Istanbul University), F. Esen(Istanbul University), S. Aghamuradov(Istanbul University), Aysen Elif Yılmaz(Istanbul University), S. K. Besisik(Istanbul University), A. A. Çağatay(Istanbul University), Mehmet Güven Günver(Istanbul University)
Cited by 6
Related Papers
Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease
|Clinical and Experimental Dermatology|2006|29
Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey
|Lara D. Veeken|2023|21
Description of damage in different clusters of patients with antiphospholipid syndrome
|Lupus|2022|12
Characteristics of Patients With Behçet Disease From the Van Province, Eastern Turkey
|JCR Journal of Clinical Rheumatology|2023|11